Stemedica Opens Enrollment in Phase II Clinical Trial for COVID-19

Stemedica Cell Technologies, Inc. ("Stemedica"), a San Diego -based biotech company specializing in the manufacture of clinical grade stem cells, announces enrollment of patients for its study entitled " A Phase II,